lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Mobile Mpox Vaccination in New York City Provided Flexible Community-Responsive Vaccine Access During the 2022 Global Mpox Emergency

24 Pages Posted: 12 Jun 2024

See all articles by Joseph Osmundson

Joseph Osmundson

New York University (NYU) - New York University

Julian L. Watkins

New York City Department of Health and Mental Hygiene

Ashwin Vasan

New York City Department of Health and Mental Hygiene

Chris Hawke

New York City Health and Hospitals Corporation

Adam Baran

New York City Health and Hospitals Corporation

Jane R. Zucker

New York City Department of Health and Mental Hygiene

Celia Quinn

New York City Department of Health and Mental Hygiene

Katya Murphy

New York City Health and Hospitals Corporation

Andrew Wallach

New York City Health and Hospitals Corporation

Theodore Long

New York City Health and Hospitals Corporation

More...

Abstract

Background: In May 2022, mpox (formerly monkeypox) began spreading globally through LGBTQ+ sexual networks. Regional transmission of mpox in west and central Africa has occurred since 2017 with little global intervention. By August 2022, New York City (NYC) became the global epicenter of the mpox outbreak, with the highest number of cases reported in the U.S.

Methods: We describe an on-site mpox vaccination strategy at commercial sex venues, nightlife venues, and pride and health centers, during August 1–November 15, 2022. Data were collected on doses, demographics, and event size to determine and evaluate vaccine uptake.

Findings: The on-site vaccination strategy resulted in 3,358 JYNNEOS doses administered at 363 events at 58 locations, including 22 events at two commercial sex venues. We show high uptake of the JYNNEOS vaccine at commercial sex venues, with as many as 60% of attendees of one event receiving a JYNNEOS vaccine dose on site. This was possible after New York City health agencies responded to community demand for second doses. Messaging about the importance and availability of vaccination at these parties was community-led. JYNNEOS vaccination via mobile clinics demonstrated less racial and geographic disparity compared to non-mobile vaccinations.

Interpretation: These results demonstrate the success of a community-led rapid response to an emergent mpox outbreak, including at places where people meet for sex.

Funding: The NYC Health + Hospitals mpox response, including the mobile JYNNEOS vaccination units, was funded via a combination of New York City resources and other governmental grants, including from New York City and State.

Declaration of Interest: The authors declare no competing interests

Ethical Approval: Because the study used only de-identified data, this study was exempt from IRB review at New York University.

Keywords: mpox, LGBTQ+, JYNNEOS, NYC, New York City

Suggested Citation

Osmundson, Joseph and Watkins, Julian L. and Vasan, Ashwin and Hawke, Chris and Baran, Adam and Zucker, Jane R. and Quinn, Celia and Murphy, Katya and Wallach, Andrew and Long, Theodore, Mobile Mpox Vaccination in New York City Provided Flexible Community-Responsive Vaccine Access During the 2022 Global Mpox Emergency. Available at SSRN: https://ssrn.com/abstract=4859548 or http://dx.doi.org/10.2139/ssrn.4859548

Joseph Osmundson

New York University (NYU) - New York University ( email )

Julian L. Watkins

New York City Department of Health and Mental Hygiene ( email )

New York City, NY
United States

Ashwin Vasan

New York City Department of Health and Mental Hygiene ( email )

New York City, NY
United States

Chris Hawke

New York City Health and Hospitals Corporation ( email )

New York, NY
United States

Adam Baran

New York City Health and Hospitals Corporation ( email )

New York, NY
United States

Jane R. Zucker

New York City Department of Health and Mental Hygiene ( email )

New York City, NY
United States

Celia Quinn

New York City Department of Health and Mental Hygiene ( email )

New York City, NY
United States

Katya Murphy

New York City Health and Hospitals Corporation ( email )

New York, NY
United States

Andrew Wallach

New York City Health and Hospitals Corporation ( email )

Theodore Long (Contact Author)

New York City Health and Hospitals Corporation ( email )

New York, NY
United States

Click here to go to TheLancet.com

Paper statistics

Downloads
105
Abstract Views
525
PlumX Metrics